Technologies and Equity Investment

Quest is an Alberta based biotechnology company developing and commercializing products to improve the quality of life.

Targeted Cancer Therapy: MAb AR9.6

• US territory licensed to Oncocare Therapeutics
• MAb AR9.6 against truncated MUC 16 for pancreatic cancer

Mutant EGF for Dermatology and Wound Healing

• Licensed from Stanford University
  
• Target indication: Wound healing
  

Quest has Equity Investment in the following companies